• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用复合聚合物支架局部给予L-703,081可减少犬冠状动脉中的血小板沉积。

Local administration of L-703,081 using a composite polymeric stent reduces platelet deposition in canine coronary arteries.

作者信息

Santos R M, Tanguay J F, Crowley J J, Kruse K R, Sanders-Millare D, Zidar J P, Phillips H R, Merhi Y, Garcia-Cantu E, Bonan R, Côté G, Stack R S

机构信息

Duke University Medical Center, Durham, North Carolina 27710, USA.

出版信息

Am J Cardiol. 1998 Sep 1;82(5):673-5, A8. doi: 10.1016/s0002-9149(98)00418-4.

DOI:10.1016/s0002-9149(98)00418-4
PMID:9732901
Abstract

We compared the effect on platelet deposition of the glycoprotein IIb/IIIa receptor antagonist L-703,081, administered locally via a drug delivery stent, with that of a standard metal stent in a canine coronary model. There was a significant reduction in platelet deposition using the L-703,081-impregnated stent compared with the bare metal stent. This study demonstrates an alternative route of delivery of GPIIb/IIIa antagonists with potential advantages over systemic administration.

摘要

在犬冠状动脉模型中,我们比较了通过药物洗脱支架局部给药的糖蛋白IIb/IIIa受体拮抗剂L-703,081与标准金属支架对血小板沉积的影响。与裸金属支架相比,使用L-703,081浸渍支架时血小板沉积显著减少。这项研究证明了糖蛋白IIb/IIIa拮抗剂的一种替代给药途径,其具有优于全身给药的潜在优势。

相似文献

1
Local administration of L-703,081 using a composite polymeric stent reduces platelet deposition in canine coronary arteries.使用复合聚合物支架局部给予L-703,081可减少犬冠状动脉中的血小板沉积。
Am J Cardiol. 1998 Sep 1;82(5):673-5, A8. doi: 10.1016/s0002-9149(98)00418-4.
2
Glycoprotein IIb/IIIa antagonist FK633 could not prevent neointimal thickening in stent implantation model of canine coronary artery.糖蛋白IIb/IIIa拮抗剂FK633不能预防犬冠状动脉支架植入模型中的内膜增厚。
Arterioscler Thromb Vasc Biol. 1999 Feb;19(2):343-7. doi: 10.1161/01.atv.19.2.343.
3
Nonpeptide glycoprotein IIb/IIIa inhibitors. 15. Antithrombotic efficacy of L-738,167, a long-acting GPIIb/IIIa antagonist, correlates with inhibition of adenosine diphosphate-induced platelet aggregation but not with bleeding time prolongation.非肽类糖蛋白IIb/IIIa抑制剂。15. 长效糖蛋白IIb/IIIa拮抗剂L-738,167的抗血栓形成疗效与抑制二磷酸腺苷诱导的血小板聚集相关,但与出血时间延长无关。
J Pharmacol Exp Ther. 1997 May;281(2):677-89.
4
Thrombosis triggered by severe arterial lesions is inhibited by oral administration of a glycoprotein IIb/IIIa antagonist.
Eur J Clin Invest. 1997 Jul;27(7):568-74. doi: 10.1046/j.1365-2362.1997.1480697.x.
5
Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb-IIIa receptors.阿昔单抗对血小板聚集的不完全抑制及糖蛋白IIb-IIIa受体阻断:糖蛋白IIb-IIIa受体内源池的重要性
Thromb Haemost. 2000 Jun;83(6):915-22.
6
Current knowledge of the platelet glycoprotein IIb/IIIa receptor antagonists for the treatment of coronary artery disease.血小板糖蛋白IIb/IIIa受体拮抗剂治疗冠状动脉疾病的当前知识。
Haemostasis. 2000;30 Suppl 3:27-43. doi: 10.1159/000054195.
7
Microcirculatory effects of abciximab and eptifibatide: a critical appraisal.阿昔单抗和依替巴肽的微循环效应:批判性评估
J Invasive Cardiol. 2003 Sep;15(9):481-3.
8
Inhibition of microsurgical thrombosis by the platelet glycoprotein IIb/IIIa antagonist SR121566A.血小板糖蛋白IIb/IIIa拮抗剂SR121566A对显微外科血栓形成的抑制作用。
Plast Reconstr Surg. 2003 Jul;112(1):177-85. doi: 10.1097/01.PRS.0000066171.65354.AE.
9
Impact of platelet glycoprotein IIb/IIIa Inhibition on the paclitaxel-eluting stent in patients with stable or unstable angina pectoris or provocable myocardial ischemia (a TAXUS IV substudy).血小板糖蛋白IIb/IIIa抑制对稳定型或不稳定型心绞痛或可诱发性心肌缺血患者紫杉醇洗脱支架的影响(TAXUS IV子研究)
Am J Cardiol. 2005 Aug 15;96(4):500-5. doi: 10.1016/j.amjcard.2005.04.009.
10
Correlation between the in vivo efficacy of GPIIb/IIIa receptor antagonists (m7E3, MK-383 and DMP-728) and ex vivo platelet inhibition.血小板糖蛋白IIb/IIIa受体拮抗剂(m7E3、MK-383和DMP-728)的体内疗效与体外血小板抑制作用之间的相关性。
Pharmacology. 1999 May;58(5):252-64. doi: 10.1159/000028288.